NO20013337D0 - New treatment - Google Patents

New treatment

Info

Publication number
NO20013337D0
NO20013337D0 NO20013337A NO20013337A NO20013337D0 NO 20013337 D0 NO20013337 D0 NO 20013337D0 NO 20013337 A NO20013337 A NO 20013337A NO 20013337 A NO20013337 A NO 20013337A NO 20013337 D0 NO20013337 D0 NO 20013337D0
Authority
NO
Norway
Prior art keywords
new treatment
treatment
new
Prior art date
Application number
NO20013337A
Other languages
Norwegian (no)
Other versions
NO20013337L (en
Inventor
Gillian Frances Atkinson
Ronald James Boon
Pierre G Vandepapeliere
Martine Anne Cecil Wettendorff
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO20013337D0 publication Critical patent/NO20013337D0/en
Publication of NO20013337L publication Critical patent/NO20013337L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
NO20013337A 1999-01-12 2001-07-05 New treatment NO20013337L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9900630 1999-01-12
PCT/EP1999/010295 WO2000041463A2 (en) 1999-01-12 1999-12-21 Combination of hepatitis b vaccine with antiviral agents

Publications (2)

Publication Number Publication Date
NO20013337D0 true NO20013337D0 (en) 2001-07-05
NO20013337L NO20013337L (en) 2001-08-17

Family

ID=10845878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013337A NO20013337L (en) 1999-01-12 2001-07-05 New treatment

Country Status (19)

Country Link
EP (1) EP1140163A2 (en)
JP (1) JP2002534438A (en)
KR (1) KR20010090011A (en)
CN (1) CN1391482A (en)
AR (1) AR022250A1 (en)
AU (1) AU760574B2 (en)
BR (1) BR9916893A (en)
CA (1) CA2359110A1 (en)
CO (1) CO5241355A1 (en)
CZ (1) CZ20012544A3 (en)
HK (1) HK1041434A1 (en)
HU (1) HUP0105070A2 (en)
IL (1) IL144186A0 (en)
NO (1) NO20013337L (en)
NZ (1) NZ512890A (en)
PL (1) PL349347A1 (en)
TR (1) TR200102024T2 (en)
WO (1) WO2000041463A2 (en)
ZA (1) ZA200105690B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1077722T1 (en) 1998-05-22 2007-02-28 Ottawa Health Research Inst Methods and products for inducing mucosal immunity
BRPI9912663B8 (en) 1998-07-31 2021-07-06 Int Inst Cancer Immunology Inc vaccine against cancer and polypeptide.
KR100863853B1 (en) 2001-03-22 2008-10-15 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 WT1 Modified Peptide
JPWO2003028758A1 (en) * 2001-09-28 2005-01-13 治夫 杉山 Method for inducing antigen-specific T cells
JP5230891B2 (en) * 2001-09-28 2013-07-10 株式会社癌免疫研究所 Novel method for inducing antigen-specific T cells
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
SI2241325T1 (en) 2002-10-29 2012-05-31 Coley Pharm Group Inc Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
WO2004053104A2 (en) 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. 5’ cpg nucleic acids and methods of use
CN100443117C (en) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 Hepatitis B treating vaccine prepn and its prepn process and use
WO2005121378A2 (en) * 2004-06-03 2005-12-22 Saint Louis University Methods and compositions for vaccination
AR065504A1 (en) * 2007-02-28 2009-06-10 Ct Ingenieria Genetica Biotech COMBINED THERAPY FOR THE TREATMENT OF CHRONIC HEPATITIS B. USE.
US20220088188A1 (en) * 2018-12-24 2022-03-24 Grand Theravac Life Science (Nanjing) Co., Ltd. Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof
CN117120088A (en) * 2021-04-07 2023-11-24 电化株式会社 Adjuvant activity enhancer and adjuvant composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414374B1 (en) * 1989-07-25 1997-10-08 Smithkline Biologicals S.A. Novel antigens and methods for their preparation
ES2273482T3 (en) * 1998-03-09 2007-05-01 Glaxosmithkline Biologicals S.A. COMPOSITIONS OF COMBINED VACCINES.

Also Published As

Publication number Publication date
NZ512890A (en) 2003-09-26
AR022250A1 (en) 2002-09-04
NO20013337L (en) 2001-08-17
TR200102024T2 (en) 2001-12-21
JP2002534438A (en) 2002-10-15
IL144186A0 (en) 2002-05-23
CA2359110A1 (en) 2000-07-20
HUP0105070A2 (en) 2002-04-29
WO2000041463A3 (en) 2000-11-09
ZA200105690B (en) 2002-09-25
EP1140163A2 (en) 2001-10-10
AU760574B2 (en) 2003-05-15
WO2000041463A2 (en) 2000-07-20
CZ20012544A3 (en) 2002-01-16
HK1041434A1 (en) 2002-07-12
CN1391482A (en) 2003-01-15
CO5241355A1 (en) 2003-01-31
AU2100900A (en) 2000-08-01
PL349347A1 (en) 2002-07-15
KR20010090011A (en) 2001-10-17
BR9916893A (en) 2001-11-20

Similar Documents

Publication Publication Date Title
FI20000863A (en) New treatment procedure
DE69924365D1 (en) MASSAGER
DK1637127T3 (en) THERAPEUTIC MICROSUM
ID26056A (en) DIAPON ONCE USE
ID26389A (en) DIAPON ONCE USE
NO20014490D0 (en) Medical mixtures
NO20032122D0 (en) Improved treatment
DE60017816D1 (en) Pacemaker
NO20005179D0 (en) Drug treatment
DE60023454D1 (en) LAGENMATERIALEN TENSID-MODIFIED CHELATBILDERN TREATED
DE69918171D1 (en) LAUNDRY TREATMENT
ID25571A (en) DIAPON ONCE USE
ID24782A (en) DIAPON ONCE USE
NO20013337L (en) New treatment
DE60016600D1 (en) PACEMAKER
DE59911113D1 (en) PACEMAKER
DE69916133D1 (en) ELECTRO-NEURO-ADAPTIVE STIMULATOR
DE60023003D1 (en) HAIR TREATMENT AGENT
DE60013608D1 (en) PACEMAKER
ATE290060T1 (en) LAUNDRY TREATMENT
DE60016452D1 (en) PACEMAKER
DE29905089U1 (en) Treatment couch
NO20012301D0 (en) New procedure for treatment
DK1043026T3 (en) melanoma treatment
SE9903421D0 (en) treatment Procedure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application